Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms BC2P |
Target |
Action inhibitors |
Mechanism BTK inhibitors(Tyrosine-protein kinase BTK inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC56H67F2N9O9 |
InChIKeyUGRJNHBWVKZNEV-YMMKHCTOSA-N |
CAS Registry- |